NCT02505594

Brief Summary

Obstructive sleep apnea (OSA) is a common disorder with major cardiovascular sequelae. A recent study confirmed that OSA is associated with impaired exercise capacity and increasing OSA severity predicts worsening exercise capacity, which is a marker of potential increased cardiovascular risk. However, potential mechanisms of decreased exercise capacity caused by OSA remain unclear. Several pathophysiologic mechanisms of OSA have been proposed and investigators hypothesize that endothelial dysfunction leading to exercise-induced right ventricular dysfunction and associated pulmonary hypertension is the potential mechanism for impaired exercise capacity in OSA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2017

Completed
Last Updated

January 5, 2018

Status Verified

January 1, 2018

Enrollment Period

1.9 years

First QC Date

July 12, 2015

Last Update Submit

January 3, 2018

Conditions

Keywords

Obstructive Sleep ApneaVasoreactivityEndothelial functionExercise

Outcome Measures

Primary Outcomes (1)

  • Endothelial function, as measured by endoPAT, between OSA patients and matched healthy controls

    EndoPAT is a non-invasive measurement of endothelial function, using peripheral arterial tonometry. Exercise tolerance is measured by Cardiopulmonary exercise testing (CPET). Effects of OSA on exercise tolerance and endothelial function will be evaluated.

    Baseline

Secondary Outcomes (14)

  • Right ventricular systolic pressure (RVSP) in response to exercise

    Baseline

  • Pulmonary systolic pressure (PASP) in response to exercise

    Baseline

  • Right ventricular outflow track (RVOT) peak velocity in response to exercise

    Baseline

  • Velocity time interval (VTI) in response to exercise

    Baseline

  • Pulmonary artery acceleration time in response to exercise

    Baseline

  • +9 more secondary outcomes

Study Arms (2)

OSA Group

Apnea-hypopnea index (AHI) ≥ 15 events/h

Control Group

Apnea-hypopnea index (AHI) \< 5 events/h

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Investigators will enroll 30 subjects with OSA (OSA group) and 30 subjects without OSA (control group). The detailed inclusion and exclusion criteria for subjects are listed below. Female subjects will be offered a urinary pregnancy test and only those documented to be non-pregnant will be studied.

You may qualify if:

  • BMI \< 30
  • OSA group: diagnosis of untreated moderate-to-severe OSA (apnea-hypopnea index (AHI) ≥ 15 events/h).
  • Control group: no OSA (AHI \< 5 events/h).

You may not qualify if:

  • Currently using Continuous Positive Airway Pressure (CPAP) or oral appliance treatment for OSA
  • Uncontrolled cardiac co-morbidity, e.g. ischemic heart disease, heart failure, or valvular heart disease that would prevent exercise
  • Uncontrolled pulmonary co-morbidity, e.g. asthma or chronic obstructive pulmonary disease (COPD)
  • Comorbidities that may severely impair peripheral circulation, e.g. uncontrolled diabetes mellitus, or systemic scleroderma
  • Neurological conditions limiting the ability to perform walking or cycling
  • Orthopedic condition limiting the ability to perform walking or cycling
  • Current smokers, alcohol (\> 3 oz/day) or use of illicit drugs.
  • Psychiatric disorder, other than mild and controlled depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Diego

San Diego, California, 92093, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBehavior

Study Officials

  • Atul Malhotra, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 12, 2015

First Posted

July 22, 2015

Study Start

July 1, 2015

Primary Completion

May 9, 2017

Study Completion

May 9, 2017

Last Updated

January 5, 2018

Record last verified: 2018-01

Locations